Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.
[read full story]
May 21, 2008 (Newswise) — Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.
BOSTON, May 22 (UPI) -- Researchers in Boston say an anti-inflammatory drug prescribed for arthritis may be beneficial in the treatment of type 2 diabetes. The Joslin Diabetes Center researchers built upon an earlier study showing the inexpensive, non-steroidal salsalate, might prevent the...
BOSTON, May 22 (UPI) -- Researchers in Boston say an anti-inflammatory drug prescribed for arthritis may be beneficial in the treatment of type 2 diabetes. The Joslin Diabetes Center researchers built upon an earlier study showing the inexpensive, non-steroidal salsalate, might prevent the...
NewsMax:Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.The paper, which appears...